Identification of differentially expressed genes induced by transient ischemic stroke

被引:53
作者
Schwarz, DA [1 ]
Barry, G [1 ]
Mackay, KB [1 ]
Manu, F [1 ]
Naeve, GS [1 ]
Vana, AM [1 ]
Verge, G [1 ]
Conlon, PJ [1 ]
Foster, AC [1 ]
Maki, RA [1 ]
机构
[1] Neurocrine Biosci Inc, San Diego, CA 92121 USA
来源
MOLECULAR BRAIN RESEARCH | 2002年 / 101卷 / 1-2期
关键词
subtraction; stroke middle cerebral artery occlusion; LOX-1;
D O I
10.1016/S0169-328X(02)00135-3
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
We have used a rat model of focal cerebral ischemia to investigate changes in gene expression that occur during stroke. To monitor these changes, we employed representational difference analysis-polymerase chain reaction (PCR). A total of 128 unique gene fragments were isolated, and we selected 13 of these for quantitative reverse transcriptase-PCR analysis. Of these 13 genes, we found seven that were differentially expressed. Four of these genes have not previously been implicated in stroke, and include neuronal activity regulated pentraxin (Narp), cystein rich protein 61 (Cyr61), Bcl-2 binding protein BIS (Bcl-2-interacting death suppressor), and lectin-like ox-LDL receptor (LOX-1). We demonstrated differential expression of each gene by quantitative PCR analysis. and in the case of LOX-1. we further confirmed differential expression by in situ hybridization. LOX-1 expression is induced greater than ten fold at the core lesion site, and is essentially localized to the ipsilateral half of the brain. LOX-1 appears to be expressed in a non-neuronal cell type, and it does not appear to be expressed in vascular endothelial cells within the brain. This suggests that LOX-1 may serve a novel function in the brain. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:12 / 22
页数:11
相关论文
共 40 条
[1]   CYR61, a product of a growth factor-inducible immediate early gene, promotes angiogenesis and tumor growth [J].
Babic, AM ;
Kireeva, ML ;
Kolesnikova, TV ;
Lau, LF .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (11) :6355-6360
[2]   Inflammatory mediators and stroke: New opportunities for novel therapeutics [J].
Barone, FC ;
Feuerstein, GZ .
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 1999, 19 (08) :819-834
[3]   Middle cerebral artery occlusion in the rat by intraluminal suture - Neurological and pathological evaluation of an improved model [J].
Belayev, L ;
Alonso, OF ;
Busto, R ;
Zhao, WZ ;
Ginsberg, MD .
STROKE, 1996, 27 (09) :1616-1622
[4]  
Belayev L., 1996, STROKE, V27, p[1616, 1623]
[5]   Increased expression of lectinlike oxidized low density lipoprotein receptor-1 in initial atherosclerotic lesions of Watanabe heritable hyperlipidemic rabbits [J].
Chen, MY ;
Kakutani, M ;
Minami, M ;
Kataoka, H ;
Kume, N ;
Narumiya, S ;
Kita, T ;
Masaki, T ;
Sawamura, T .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2000, 20 (04) :1107-1115
[6]   The expression of the lectin-like oxidized low-density lipoprotein receptor (LOX-1) on human vascular smooth muscle cells and monocytes and its down-regulation by lovastatin [J].
Draude, G ;
Hrboticky, N ;
Lorenz, RL .
BIOCHEMICAL PHARMACOLOGY, 1999, 57 (04) :383-386
[7]  
FISHER M, 1995, BAILLIERE CLIN NEUR, V4, P279
[8]   RODENT MODELS OF CEREBRAL-ISCHEMIA [J].
GINSBERG, MD ;
BUSTO, R .
STROKE, 1989, 20 (12) :1627-1642
[9]   Experimental models for the investigation of brain ischemia [J].
Hossmann, KA .
CARDIOVASCULAR RESEARCH, 1998, 39 (01) :106-120
[10]   VIABILITY THRESHOLDS AND THE PENUMBRA OF FOCAL ISCHEMIA [J].
HOSSMANN, KA .
ANNALS OF NEUROLOGY, 1994, 36 (04) :557-565